Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-30

FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for divalproex sodium submitted by Zydus Pharmaceuticals USA Inc. The specific changes covered by the supplement are not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIVALPROEX SODIUM (divalproex sodium)

Snippet

SUPPL AP for DIVALPROEX SODIUM (DIVALPROEX SODIUM)